These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 9268710)
1. Selective interaction of protein kinase FA/glycogen synthase kinase-3alpha with membrane phospholipids. Yu JS; Chan WH; Yang SD Biochem Biophys Res Commun; 1997 Aug; 237(2):331-5. PubMed ID: 9268710 [TBL] [Abstract][Full Text] [Related]
2. Reversible tyrosine phosphorylation/dephosphorylation of proline-directed protein kinase FA/glycogen synthase kinase-3alpha in A431 cells. Yu JS; Chen HC; Yang SD J Cell Physiol; 1997 Apr; 171(1):95-103. PubMed ID: 9119896 [TBL] [Abstract][Full Text] [Related]
3. Association of protein kinase FA/GSK-3alpha (a proline-directed kinase and a regulator of protooncogenes) with human cervical carcinoma dedifferentiation/progression. Yang SD; Yu JS; Lee TT; Ni MH; Yang CC; Ho YS; Tsen TZ J Cell Biochem; 1995 Oct; 59(2):143-50. PubMed ID: 8904308 [TBL] [Abstract][Full Text] [Related]
4. Human serum and glucocorticoid-inducible kinase-like kinase (SGKL) phosphorylates glycogen syntheses kinase 3 beta (GSK-3beta) at serine-9 through direct interaction. Dai F; Yu L; He H; Chen Y; Yu J; Yang Y; Xu Y; Ling W; Zhao S Biochem Biophys Res Commun; 2002 May; 293(4):1191-6. PubMed ID: 12054501 [TBL] [Abstract][Full Text] [Related]
5. Dysfunction of protein kinase FA/GSK-3 alpha in lymphocytes of patients with schizophrenic disorder. Yang SD; Yu JS; Lee TT; Yang CC; Ni MH; Yang YY J Cell Biochem; 1995 Sep; 59(1):108-16. PubMed ID: 8530529 [TBL] [Abstract][Full Text] [Related]
6. Additional binding sites for anionic phospholipids and calcium ions in the crystal structures of complexes of the C2 domain of protein kinase calpha. Ochoa WF; Corbalán-Garcia S; Eritja R; Rodríguez-Alfaro JA; Gómez-Fernández JC; Fita I; Verdaguer N J Mol Biol; 2002 Jul; 320(2):277-91. PubMed ID: 12079385 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of cellular activity and protein level of protein kinase FA/GSK-3 alpha correlates with human thyroid tumor cell dedifferentiation. Lee TT; Ho YS; Yu JS; Yang SD J Cell Biochem; 1995 Aug; 58(4):474-80. PubMed ID: 7593269 [TBL] [Abstract][Full Text] [Related]
8. Tyrosine dephosphorylation and concurrent inactivation of protein kinase FA/GSK-3 alpha by genistein in A431 cells. Yu JS; Yang SD J Cell Biochem; 1994 Sep; 56(1):131-41. PubMed ID: 7806586 [TBL] [Abstract][Full Text] [Related]
9. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease. Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173 [TBL] [Abstract][Full Text] [Related]
10. Pancreastatin, a chromogranin-A-derived peptide, inhibits insulin-stimulated glycogen synthesis by activating GSK-3 in rat adipocytes. González-Yanes C; Sánchez-Margalet V Biochem Biophys Res Commun; 2001 Nov; 289(1):282-7. PubMed ID: 11708813 [TBL] [Abstract][Full Text] [Related]
11. The effects of glucose and the hexosamine biosynthesis pathway on glycogen synthase kinase-3 and other protein kinases that regulate glycogen synthase activity. Singh LP; Crook ED J Investig Med; 2000 Jul; 48(4):251-8. PubMed ID: 10916283 [TBL] [Abstract][Full Text] [Related]
12. The naturally occurring PKC inhibitor sphingosine and tumor promoter phorbol ester potentially induce tyrosine phosphorylation/activation of oncogenic proline-directed protein kinase FA/GSK-3alpha in a common signalling pathway. Lee SC; Kuan CY; Wen ZD; Yang SD J Protein Chem; 1998 Jan; 17(1):15-27. PubMed ID: 9491924 [TBL] [Abstract][Full Text] [Related]
13. Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation. Martinez A; Castro A; Dorronsoro I; Alonso M Med Res Rev; 2002 Jul; 22(4):373-84. PubMed ID: 12111750 [TBL] [Abstract][Full Text] [Related]
14. Dual effects of PKNalpha and protein kinase C on phosphorylation of tau protein by glycogen synthase kinase-3beta. Isagawa T; Mukai H; Oishi K; Taniguchi T; Hasegawa H; Kawamata T; Tanaka C; Ono Y Biochem Biophys Res Commun; 2000 Jun; 273(1):209-12. PubMed ID: 10873588 [TBL] [Abstract][Full Text] [Related]
15. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Ferrer I; Barrachina M; Puig B Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379 [TBL] [Abstract][Full Text] [Related]
17. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734 [TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3 regulation of chromatin segregation and cytokinesis in mouse preimplantation embryos. Acevedo N; Wang X; Dunn RL; Smith GD Mol Reprod Dev; 2007 Feb; 74(2):178-88. PubMed ID: 16941690 [TBL] [Abstract][Full Text] [Related]
19. Nuclear glycogen and glycogen synthase kinase 3. Ragano-Caracciolo M; Berlin WK; Miller MW; Hanover JA Biochem Biophys Res Commun; 1998 Aug; 249(2):422-7. PubMed ID: 9712712 [TBL] [Abstract][Full Text] [Related]
20. Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45. Hagen T; Vidal-Puig A Biochem Biophys Res Commun; 2002 Jun; 294(2):324-8. PubMed ID: 12051714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]